✦ LIBER ✦

Corrigendum to “Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy” [Lung Cancer 69S1 (2010) S11–S18]

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to “Cost-effectiveness analy

✍ Giuliani, Giovanni; Grossi, Francesco; de Marinis, Filippo; Walzer, Stefan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Corrigendum to “Cost-effectiveness analy

✍ Giuliani, Giovanni; Grossi, Francesco; de Marinis, Filippo; Walzer, Stefan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Cost-effectiveness analysis of bevacizum

✍ Giuliani, Giovanni; Grossi, Francesco; de Marinis, Filippo; Walzer, Stefan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Corrigendum to “Effectiveness of bevaciz

✍ Nuijten, Mark; Heigener, David F.; Bischoff, Helge G.; Chouaid, Christos; Vergne 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Corrigendum to “Effectiveness of bevaciz

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 262 KB

PCN87 A COST-EFFECTIVENESS ANALYSIS OF B

✍ HG Bischoff; D Heigener; C Wiesner; S Walzer 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB